29.1 C
Vientiane
Saturday, June 28, 2025
spot_img
Home Blog Page 48

Sigenergy’s 20 MWh Modular C&I Solution Defines the Next Generation of Energy Storage

BURGAS, Bulgaria, June 4, 2025 /PRNewswire/ — Sigenergy brought together nearly 300 global energy professionals in Burgas to explore the future of commercial and industrial (C&I) energy storage. A key highlight of the event was a visit to a landmark 20 MWh project in Malko Tarnovo, powered by Sigenergy’s modular C&I battery energy storage system (BESS). The project highlights the scalability and real-world impact of next-generation storage technology.

Sigenergy’s 20 MWh Modular C&I Solution in Bulgaria
Sigenergy’s 20 MWh Modular C&I Solution in Bulgaria

In partnership with Trakia MT Ltd., a leading Bulgarian solar company, the system is installed on a solar farm and features 90 Sigenergy C&I hybrid inverters combined with the SigenStack modular storage solution.

Tony Xu, Founder and CEO of Sigenergy, commented: “Sigenergy’s mission is to accelerate the global transition to clean energy with innovative and scalable storage solutions. This project exemplifies how advanced battery systems can drive business growth and decarbonization across industries.”

Modularity Transforming C&I Energy Storage

SigenStack introduces a truly modular approach to C&I energy storage—replacing bulky containerized systems with stackable 12 kWh battery packs. With plug-and-play connectors and tool-free installation, the system eliminates complex wiring, the need for cranes, and heavy machinery.

Thanks to this design, the entire 20 MWh system was installed in just 10 days and fully commissioned within 2 days. Galina Peycheva-Miteva, Owner of Trakia MT Ltd., noted: “The installation was incredibly smooth—more like assembling building blocks than deploying industrial infrastructure. This modular design is a game-changer for the C&I energy storage sector.”

Safety Engineered at the Pack Level

Sigenergy’s C&I BESS solutions set new benchmarks for system safety. At the heart of this innovation is the SigenStack system, engineered with safety at every level. Each 12 kWh battery pack features six layers of protection: temperature sensors, internal fire suppression units, aerogel insulation, decompression valves, high-temperature-resistant insulation pads, and smoke detectors. This configuration enables early detection of thermal runaway at the pack level and initiates a rapid, localized response within seconds.

In contrast, conventional cabinet-style systems typically lack compartmentalization and may take over a minute to react, increasing the risk of fire propagation. By isolating incidents at the module level, SigenStack significantly enhances system reliability and operational safety.

Its advanced inverter platform includes ultra-fast 500 ms anti-backflow protection and long-range arc fault circuit interrupter (AFCI) technology capable of detecting faults up to 500 meters.

To further validate its safety performance, Sigenergy partnered with global assurance provider Intertek to publish a C&I Safety White Paper. The results confirm full compliance with UL 9540A and IEC 62619, structural stability under extreme testing, and sustained operational efficiency above 95%.

Resilience Made for Zero Maintenance

Built on robust safety and modular design, Sigenergy’s C&I BESS supports 24/7 autonomous operation. With an IP66 rating for dust and water resistance, it delivers reliable performance across diverse environmental conditions. Conventional cabinet-style systems, however, often contain more vulnerable components and demand monthly inspections, half-year part replacements, and comprehensive annual maintenance.

Real-time monitoring via a cloud-based platform provides full visibility into system status, energy throughput, and alarms, significantly reducing the need for on-site inspections. Maintenance is also streamlined: faulty battery packs can be replaced individually within two hours, without full system diagnostics or on-site technician intervention. This reduces downtime, simplifies spare parts logistics, and minimizes operational costs.

The successful delivery of this project demonstrates Sigenergy’s excellence in installation speed, safety, operational reliability, and smart management. Looking ahead, Sigenergy is committed to expanding its global footprint, driving the adoption of safer, more efficient, and sustainable energy solutions worldwide.

PayJoy Marks 10 Years and 15 Million Customers: Focused on Expanding Responsible Financing in Emerging Markets

SAN FRANCISCO, June 4, 2025 /PRNewswire/ — PayJoy, a Public Benefit Corporation focused on bringing responsible financing to underserved customers in emerging markets, is marking its 10th year of operations. Since 2015, the company has served over 15 million customers and is on track to reach $650 million in revenue and $110 million in profit by the end of 2025.

PayJoy began with one simple idea: helping first-time borrowers finance smartphones they need for work, school, and family connection—often when no other lender would. Using its proprietary phone-security technology and alternative credit models, PayJoy created a new form of secured lending tailored to the realities of low-income, thin-file customers.

PayJoy’s growth has been built through high-growth expansion of its smartphone financing product, and more recently, a revolving credit line and the PayJoy Card, which allow customers to build credit over time and meet day-to-day financial needs. These newer products now drive a growing share of the company’s profitability, especially in Mexico and Colombia.

Looking forward, the company is piloting a digital wallet and plans to expand into remittances, bill pay, and insurance—always with the intent to meet customers where they are. Doug Ricket, PayJoy CEO and founder said, “Our customers have huge potential that we can help unlock. If we continue listening to them and building what they actually need to succeed financially, I believe we can make a real difference at scale.”

About PayJoy
PayJoy is a Public Benefit Corporation providing responsible financing to underserved populations in emerging markets. Using proprietary phone-security technology and AI-driven underwriting, PayJoy helps borrowers build credit and access digital tools for work, education, and connection. Learn more at www.payjoy.com.

H World Group Releases 2024 Sustainability Report, Advancing Sustainable Development through Service Innovation and Green Operations

SHANGHAI, June 3, 2025 /PRNewswire/ — H World Group Limited (NASDAQ:HTHT) (HK:01179), a leading hospitality group, has released its 2024 Sustainability Report, reaffirming its commitment to  sustainable growth powered by innovation, inclusion, and bold environmental action.  Recognized as the “Outstanding ESG Practice Cases of 2024” by the China Association for Public Companies, the company continued to enhance its ESG practices and drive sustainable development across the industry.

JI Hotel Xiao Shanqing "Guest Listening" Zone
JI Hotel Xiao Shanqing “Guest Listening” Zone

The report outlines the Group’s commitments, strategies, management efforts, and achievements across 6 key dimensions: corporate governance, service excellence, employee well-being, industry advancement, environmental responsibility, and social contribution.

Advancing a Greener Future Through Low-Carbon Innovation

H World advanced its green vision through 3 key pillars: green buildings, green operations, and green services, in partnership with its global ecosystem”.

  • Green Buildings: Flagship products such as Hanting 3.5, JI Hotel 5.0, and Hi Inn 2.0 have adopted modular construction techniques, enabling faster construction, superior quality, and significantly lower environmental footprints.
  • Green Operations: Environmental criteria were integrated into supplier partnerships, advancing initiatives like eco-friendly materials, smart linen management, and sustainable laundry systems to reduce resource consumption.
  • Green Services: The “Green Living” program in China encouraged 872,000 guest stays to opt out of towel replacement. The program has reduced over 7.88 million pieces of towel laundry, saving over 24,000 tons of water, 680 MWh of electricity, and preventing 676 tons of carbon emissions. The program was powered by a partnership with Alipay, combining hospitality and fintech innovation for measurable impact.

Empowering Employees for Meaningful Careers

H World is proud to champion female leadership across all levels of the organization. H World has 28,502 full-time employees by the end of 2024, 62.4% of whom are women. Within its China operations, 59.6% of all hotel general managers are female. On H World’s Board of Directors, female directors accounted for 42.9%.

H World partnered with over 130 universities in 100+ cities across 27 provinces have created over 2,600 annual internship positions. In 2024, H World was recognized by the Ministry of Education as an “Outstanding Industry-Academia Cooperation Case” and named one of the “Most Popular Employers Among Chinese University Students” by 51job, one of China’s largest recruitment platforms.

H World International received the “Best Trainer in Germany” award from Capital magazine.

Giving Back to Society and Building Caring Communities

H World actively fulfills its corporate social responsibility through long-standing public welfare initiatives:

  • Following the severe floods in Guilin, Guangxi in June 2024, H World opened its hotel lobbies and restaurants to affected residents, offering shelter, hot water, charging stations, and internet access.
  • In support of rural revitalization, H World promoted an integrated  Hotel + Rural Economy  model. Notably, JI Hotel has partnered with Zhenghe County in Fujian Province for 6  consecutive years to procure 3 0,000 kilograms of local tea annually and developed an eco-farm demonstration site in Wuchang  County , Heilongjiang  Province .
  • Launched in 2016, the  Scholarly HanTing  online teaching initiative has expanded its reach to support more students in remote rural schools. The program provides high-quality educational resources for children and offers professional training for local teachers, helping to bridge the rural education gap.

Effective Governance as the Cornerstone of Sustainability

H World continued to elevate its service standards through strengthened safety measures, diversified offerings, and breakthroughs in digital innovation.

The Group also established a Security Assurance Committee, led directly by the CEO, to oversee guest safety. It has enacted 16 internal policies, including the Information Security Management Framework, as well as data privacy statements for both individual and corporate members.

To support suppliers in improving product and service quality, Legacy Huazhu partnered with external auditing agencies to establish a third-party supplier audit assessment system. In 2024, a total of 972 audits were conducted, covering 699 suppliers. The audit coverage rate for strategic and key suppliers reached 98%.

You can download the H World Group Limited 2024 Sustainability Report at:
https://ir.hworld.com/system/files-encrypted/nasdaq_kms/assets/2025/05/29/22-17-22/H%20World%202024%20Sustainability%20Report.pdf

*Unless otherwise noted, the data presented refers to the year 2024 or as of the end of the reporting period. 

About H World Group Limited

Originated in China, H World Group Limited (NASDAQ:HTHT) (HK:01179) is a key player in the global hotel industry. H World’s brands include HanTing Hotel, JI Hotel, Crystal Orange Hotel, Steigenberger Hotels & Resorts, MAXX, Jaz in the City, IntercityHotel, Zleep Hotels and Steigenberger Icons. In addition, H World also has the rights as master franchisee for Mercure, Ibis and Ibis Styles, and co-development rights for Grand Mercure and Novotel, in the pan-China region.

For more information, please visit H World’s website: https://ir.hworld.com

For m edia i nquiry, please contact:
Lihuan Wang media@hworld.com
Zheming Xing zheming@taskforce-china.cn
Zhibin Lang  zhibin.lang@taskforce-china.cn

 

ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis

TOKYO, June 3, 2025 /PRNewswire/ — ThinkCyte, a life science company pioneering advanced AI-powered cell analysis and sorting technologies, today announced the pre-commercial launch of MorphoScan Cloud, its new cloud-based platform designed for flexible data access, faster processing, and advanced AI–driven analysis. The launch coincides with the 38th Annual Congress of the International Society for the Advancement of Cytometry (CYTO 2025), held in Denver, Colorado from May 31 to June 4.

MorphoScan Cloud expands the user experience for customers of VisionSort, ThinkCyte’s flagship morphometric cell analysis and sorting platform. With secure cloud storage and multi-user access capabilities, MorphoScan Cloud enables research teams across geographies to centralize, share, and analyze VisionSort-generated data more efficiently.

With an integrated suite of advanced analytical tools, purpose-built to unlock deeper biological insights from complex cellular data, MorphoScan Cloud is the next step in ThinkCyte’s commitment to bringing advanced morphometric profiling hardware and software solutions to life science research. Whether applying supervised or unsupervised learning techniques, users will be able to leverage cloud computing  to explore their datasets using advanced  algorithms including deep learning.

“With MorphoScan Cloud, we’re providing our customers with more than just storage – we’re offering an intelligent platform that transforms how research teams engage with cellular data,” said Waichiro Katsuda, CEO of ThinkCyte. “By combining the new view of biology provided by VisionSort with the analytical power of AI with the accessibility of the cloud, we aim to streamline data analysis workflows, accelerate discovery, and empower innovation across the life sciences.”

Attendees at CYTO 2025 can experience MorphoScan Cloud firsthand at the ThinkCyte booth (#627) or more information, visit https://thinkcyte.com/mkt/morphoscan-cloud/

About ThinkCyte

ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific research platforms based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development. The company developed Ghost Cytometry™, a proprietary AI-based, label-free cell analysis and sorting technology and partners with major global biopharmaceutical companies and leading academic research institutes to drive pioneering research. For more information, please visit www.thinkcyte.com.

Schneider Electric, Siemens AG, and GE Vernova Take Top Spots in ABI Research’s Energy Grid Digitalization Technologies Competitive Ranking

LONDON, June 3, 2025 /PRNewswire/ — A new Competitive Ranking by global intelligence firm ABI Research finds that Schneider Electric is the leading provider of energy grid digitalization technology, beating Siemens AG and GE Vernova to the top spot overall with its comprehensive portfolio of solutions, leading the market across innovation and implementation criteria.

The ranking evaluated eight technology vendors on a wide range of key criteria, including the strength of their individual ADMS, DERMS, EMS, GIS, and associated technologies, as well as the comprehensiveness of their total ‘grid management’ suites and the synergy between constituent products. The evaluation also examined the geographical reach and depth of each vendor’s partnerships, the extent to which their solutions are adopted by transmission and distribution operators, and the efficacy of their related sustainability, ecosystem, cybersecurity, and go-to-market strategies.

Companies assessed and ranked include:

Market Leaders: Schneider Electric, Siemens AG, GE Vernova
Mainstream:Hitachi Energy, ABB
Followers: Mitsubishi Electric Power Products Inc., Honeywell

“As capacity problems hamstring electricity networks and distributed renewable assets complicate grid management, the operational improvement and expansion of energy grids have rapidly become top priorities for operators and utilities. Consequently, technologies – from digital grid twins and AI forecasting software to virtual substations and advanced metering – which improve planning and operational efficiency have become essential. Transmission and distribution operators, as well as utilities, are increasingly seeking partnerships with vendors who offer these digital solutions,” explains Daniel Burge, Research Analyst at ABI Research.

Schneider Electric positioned first thanks to its market-leading innovations in ADMS, DERMS, OMS, energy and energy flexibility trading, virtual substations, and cybersecurity offerings. Schneider Electric also boasts exceptional market presence, a uniquely strong ecosystem approach, and a firm commitment to sustainability and sustainable improvement across its suite of energy grid solutions.

According to Burge, “Those operating energy networks are experiencing acute pressures to adapt to critical challenges – from every angle. They must plan and expand total grid capacity to account for rising demand, improve their monitoring, maintenance, and bidirectional energy management practices to accommodate for the spread of privately-owned energy assets, and handle grid congestion driven by renewable intermittency. Therefore, when digitalizing their networks, system operators will benefit most from partnerships with those vendors offering a full range of high-quality, innovative, and synergized software and hardware solutions.”

While Schneider Electric, Siemens, and GE Vernova led the overall rankings, other ranked vendors are also rapidly innovating in this relatively nascent market. Hitachi Energy, which narrowly missed the top three, has produced the industry’s first dedicated AI solution – Nostradamus AI – and is driving the development of complex wildlife management solutions. Likewise, Mitsubishi Electric Power Products Inc.’s novel approach to substation monitoring is one to watch.

“Evidently, as the market for energy grid digital solutions matures, it will find no shortage of technological innovation – or competition,” Burge concludes.

These findings are from ABI Research’s Energy Grid Digitalization Technologies Competitive Ranking report. This report is part of the company’s Smart Energy for Enterprises and Industries research service, which includes research, data, and ABI Insights. 

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司,拥有得天独厚的优势,充当终端市场公司和技术解决方案提供商之间的桥梁,通过提供独家研究和专业性指导,推动成功的技术实施和提供经证明可吸引和留住客户的战略,无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info:
Global
Jason Scheer
Tel: +1.516.624.2562
pr@abiresearch.com

 

Hyundai Motor Company President and CEO José Muñoz Reinforces Hyundai’s Journey as a Mobility Leader at FISITA World Mobility Conference 2025

  • Hyundai Motor Group showcases its future mobility vision and technology innovations at the FISITA World Mobility Conference 2025 in Barcelona, Spain
  • Hyundai Motor Company President and CEO José Muñoz delivered the Principal Speech, underscoring Hyundai’s journey as a mobility leader
  • ChangHwan Kim, Executive Vice President and Head of Electrification Energy Solutions Tech Unit at Hyundai Motor Group, began his term as the first Korean FISITA President
  • The all-new NEXO and the enhanced fuel cell system are exhibited during the conference, highlighting the Group’s cutting-edge hydrogen mobility technology

SEOUL, South Korea and BARCELONA, Spain, June 3, 2025 /PRNewswire/ — Hyundai Motor Group (the Group) reaffirms its vision for the future of mobility and its leadership in technological innovation at the La Fédération Internationale des Sociétés d’Ingénieurs des Techniques de l’Automobile (FISITA) World Mobility Conference (WMC) 2025, held from June 3 to 5 at the Palau de Congressos de Catalunya in Barcelona, Spain.

Hyundai Motor Company President and CEO José Muñoz
Hyundai Motor Company President and CEO José Muñoz

FISITA, the world’s largest association of academic institutions in the automotive field, unites engineering societies from 36 countries and has cultivated a global network of approximately 210,000 automotive researchers since its establishment in 1948. Its biennial conference, FISITA WMC, convenes around 2,000 distinguished executives and engineers from the mobility industry.

As Prime Partner of FISITA WMC, the Group underscores its commitment to shaping the future of sustainable mobility by delivering a networking program, technical sessions, paper presentations, and an exhibition. Hyundai Motor Company President and CEO José Muñoz set the tone for the conference with his Principal Speech, engaging with industry leaders and engineers under the theme of Hyundai’s journey as a mobility leader.

“As an engineer myself, it was a real pleasure to share Hyundai’s mobility journey and engage with participants at the FISITA World Mobility Conference. Under the leadership of Hyundai’s Executive Chair, we are pushing the technological boundaries of what’s currently possible to improve how people and goods will move more safely, sustainably and conveniently. Thank you to the organizers and congratulations to my colleague ChangHwan Kim for being named as the first Korean president of FISITA.”

ChangHwan Kim, Executive Vice President and Head of Electrification Energy Solutions Tech Unit at Hyundai Motor Group, who was inducted as president of FISITA at the conference, will guide the organization throughout his tenure until May 2027, overseeing the Executive Board and Committees.

The Group will also host a special technical session from June 4 to 5, highlighting its latest advancements and collaborative research with European partners. Key topics include methodologies and case studies on the use of software and hardware, such as driving simulators for virtual performance verification, new bushing technologies to enhance ride comfort and performance in EVs and research on ensuring chassis reliability in software-defined vehicles using prognostics and health management technologies.

Under the theme ‘Clearly Committed, FCEV Technology,’ the all-new NEXO and the enhanced fuel cell system will be exhibited, reiterating Hyundai Motor Group’s leadership in hydrogen mobility and showcasing its dedication to driving innovation as a smart solutions provider across the full mobility ecosystem.

By sharing its vision and technological capabilities throughout the conference, Hyundai Motor Group aims to foster global academic collaboration in mobility research while solidifying its role as a catalyst for innovation in the automotive industry, all in line with its vision of ‘Progress for Humanity.’

About Hyundai Motor Group

Hyundai Motor Group is a global enterprise that has created a value chain based on mobility, steel, and construction, as well as logistics, finance, IT, and service.

(from left) Chris Mason, CEO of FISITA; José Muñoz, Hyundai Motor Company President and CEO; ChangHwan Kim, Executive Vice President and Head of Electrification Energy Solutions Tech Unit at Hyundai Motor Group
(from left) Chris Mason, CEO of FISITA; José Muñoz, Hyundai Motor Company President and CEO; ChangHwan Kim, Executive Vice President and Head of Electrification Energy Solutions Tech Unit at Hyundai Motor Group


Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach

  • Phase IIa study results of Rentosertib were published simultaneously in Nature Medicine(IF = 58.7) and presented at the American Thoracic Society (ATS) 2025.
  • Encouraging clinical data showed that patients receiving 60 mg QD Rentosertib experienced the greatest mean improvement in lung function, as measured by forced vital capacity (FVC), with a mean change of +98.4 mL, compared to a mean decline of -20.3 mL in the placebo group.
  • Exploratory biomarkers analyses further validated the biological mechanism of TNIK, the novel target identified through a generative AI approach, supporting Rentosertib’s potential anti-fibrotic and anti-inflammatory effects.

CAMBRIDGE, Mass., June 3, 2025 /PRNewswire/ — Artificial intelligence (AI) is rapidly transforming the pharmaceutical industry, reshaping the landscape from target identification to personalized medicine, and unlocking unprecedented opportunities to accelerate drug discovery and delivery. Despite growing adoption, only a few AI-discovered or AI-designed drug candidates have advanced to clinical trials, and even fewer have demonstrated clinical proof-of-concept.


On June 3, 2025, the industry’s first proof-of-concept clinical validation of AI-driven drug discovery was published in Nature Medicine. Insilico Medicine and collaborators reported promising safety and efficacy results from a Phase IIa trial of Rentosertib (known as ISM001-055), a TNIK inhibitor developed using Insilico’s generative AI platform, Pharma.AI, for idiopathic pulmonary fibrosis (IPF). Additionally, the exploratory analysis of biomarkers in this paper further validated the biological mechanism of TNIK inhibition, the novel target identified through a generative AI approach, supporting Rentosertib’s potential anti-fibrotic and anti-inflammatory effects.

“These results not only suggest that Rentosertib has a manageable safety and tolerability profile, but also warrants further investigation in larger-scale clinical trials of longer duration, demonstrating the transformative potential of AI in drug discovery and development and paving the way for faster and more innovative therapeutic advancements,” Said Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine.

“We are thrilled that our research findings have been published in Nature Medicine. Rentosertib represents a truly innovative therapeutic, with both its target identification and molecular design powered by AI—an approach that is pioneering in the pharmaceutical industry. IPF remains a highly challenging disease with significant unmet clinical needs. This study demonstrates that Rentosertib has the potential to provide meaningful clinical benefits for IPF patients, which is truly exciting. However, the sample size in each patient group was relatively limited, and these findings will need to be validated in larger cohort studies.” said Dr. Zuojun Xu, Professor at the Peking Union Medical College and the lead investigator of the Phase IIa clinical trial of Rentosertib in IPF patients.

The Phase IIa GENESIS-IPF trial (Generative AI Enabled Novel Experimental Study of ISM001-055 in Subjects with Idiopathic Pulmonary Fibrosis) reported in this paper is a double-blind, placebo-controlled trial that enrolled 71 patients with IPF across 22 sites in China. Participants were randomly assigned to receive either placebo, 30 mg Rentosertib once daily (QD), 30 mg twice daily (BID), or 60 mg QD for 12 weeks.

The results demonstrated that Rentosertib exhibited a manageable safety and tolerability profile, with similar rates of treatment-emergent adverse events (TEAEs) observed across all treatment groups, thereby meeting the primary endpoint. Most adverse events (AEs) were mild to moderate in severity, and serious adverse events (SAEs) were rare. Notably, all adverse events resolved following discontinuation of treatment.

Promising outcomes were also observed for the secondary efficacy endpoint, with a dose-dependent improvement in forced vital capacity (FVC), the gold-standard metric assessing lung function in IPF patients. Patients receiving 60 mg QD Rentosertib showed the greatest mean improvement in lung function, with a mean FVC increase of +98.4 mL, compared to a mean decline of -20.3 mL in the placebo group.

In addition, as an exploratory study, patient serum samples were collected throughout the trial and analyzed for protein profiles to investigate both the mechanism of action and the potential prognostic or predictive biomarkers of response to Rentosertib treatment.

The results revealed dose- and time-dependent changes in serum protein levels and FVC after 12 weeks of treatment, further supporting Rentosertib’s anti-fibrotic and anti-inflammatory effects. In the high-dose group, profibrotic proteins such as COL1A1, MMP10, and FAP were significantly reduced, while the anti-inflammatory marker IL-10 was increased. Notably, these protein changes correlated with improvements in FVC. Collectively, these findings are consistent with preclinical observations and provide valuable guidance for dose selection and biomarker identification in future clinical validations.

The data from this study were presented in oral presentations and a poster presentation at the American Thoracic Society (ATS) 2025 International Conference. In light of these encouraging study results, Insilico has begun discussions with regulatory authorities to facilitate the prospective evaluation of Rentosertib in larger cohorts of patients.

By integrating advanced AI and automation technologies, Insilico Medicine has demonstrated significant efficiency improvements in practical applications, setting a benchmark for AI-driven drug research and development. Compared to the typical 2.5–4 years required in traditional drug discovery, Insilico’s 22 nominated candidate drugs from 2021 to 2024 took only 12–18 months on average to progress from project initiation to nomination of preclinical candidates (PCCs), with each project requiring synthesis and testing of only about 60–200 molecules. The success rate from PCC to IND-enabling stage reached 100%.

About Rentosertib (Known as ISM001-055)

Rentosertib is a potentially first-in-class small molecule targeting TNIK developed utilizing generative AI. In IPF, the activation of TNIK drives pathological fibrosis in the lungs, contributing to the progressive decline in lung function. By inhibiting TNIK, Rentosertib aims to halt or reverse fibrotic processes, offering a disease-modifying treatment for patients with IPF. The history of discovery, design and development including target discovery, generative chemistry, multiple in-vitro and in-vivo experiments as well as the results of Phase I clinical studies in human volunteers were published in a Nature Biotechnology article in March 2024.

About Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, scarring lung disease characterized by a progressive and irreversible decline in lung function. Affecting approximately 5 million people worldwide, IPF carries a poor prognosis, with a median survival of 3 to 4 years. Current approved treatments, including antifibrotic drugs, can slow disease progression but do not stop or reverse it, leaving a significant unmet need for more effective, disease-modifying therapies.

About Insilico Medicine

Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry, medicine and science research using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. www.insilico.com

Two Ivy League Institutions Select 3CLogic Voice AI and Contact Center Solution for ServiceNow to Transform IT Help Desks

Voice AI and cloud contact center solution enables smarter service delivery, automation, real-time insights, and unified ServiceNow experience for academic institutions

ROCKVILLE, Md., June 3, 2025 /PRNewswire/ — 3CLogic, the leading AI-powered contact center platform purpose-built for ServiceNow®, today announced that two globally recognized academic institutions, both with extensive ServiceNow ITSM deployments, have recently selected it to overcome critical pain points within their IT service desk operations. Both organizations were eager to replace existing solutions, with one operating a legacy on-premise system and the other struggling with limited visibility, fragmented user experiences, and over-reliance on external resources for daily administrative needs. 

As digital transformation continues to reshape the landscape of higher education, top-tier universities are turning to 3CLogic to modernize and enhance their IT help desks while maximizing their current and future investments in ServiceNow. By replacing existing systems with a cloud-based Contact Center as a Service (CCaaS) solution designed to complement the Now Platform®, institutions are driving operational efficiency, unified agent experiences, and better support outcomes for faculty, students, and staff.

Unifying ITSM and Voice for a Seamless Experience

Both universities cited the need for a platform based approach in which their voice and contact center needs are woven together with ServiceNow data and workflows, rather than operating alongside them. With the adoption of 3CLogic, agents and service desk managers will benefit from a single pane of glass for incident management, call handling, contact center administration, reporting, and real time decision making, all without leaving ServiceNow.

Driving Autonomy and Rapid Response with AI

Self-service configuration and autonomy were among the key drivers. Each university will leverage 3CLogic’s native AI capabilities integrated with ServiceNow, including intelligent voice self-service, call transcription, and speech analytics to improve intelligent call deflection (i.e.: major incident automation, etc.), reduce agent manual tasks (i.e.: call notes, etc.), lower after-hours service costs, and enable independent management of daily service desk operations without needing constant intervention from internal IT or expensive third-party consultants. 

Enabling Agents and Empowering Leadership

Leveraging smart voice workflows and identification, each university will be able to seamlessly route critical calls (i.e.: research and medical divisions, etc.) in need of live assistance to the most qualified agents with relevant historical context to enable personalized experiences. Meanwhile, voice and contact center data, once siloed or difficult to correlate, will now integrate with ServiceNow dashboards and Platform Analytics to support data-driven decision-making and deliver immediate value to leadership teams seeking better visibility into service metrics. 

These latest selections underscore the growing demand among higher education institutions for a fully integrated approach to IT service management and voice. As the role of technology in education continues to evolve, 3CLogic remains a trusted partner in helping institutions maximize the value of their ServiceNow investments while delivering seamless, AI-powered support experiences. For more information, please contact info@3clogic.com.

About 3CLogic
3CLogic transforms customer and employee experiences with its patented and award-winning AI-powered cloud contact center solutions purpose-built to enhance today’s leading CRM and Customer Service Management platforms. Globally available and leveraged by the world’s leading brands, its offerings empower enterprise organizations with innovative capabilities, such as intelligent self-service, Generative AI, Voice AI, agent automation & coaching, and AI-powered sentiment analytics — all designed to lower operational costs, maximize ROI, and deliver better, faster, and more personalized interactions for IT, employee, and customer service. For more information, please visit www.3clogic.com.